Abstract
e21639Background: Febrile neutropenia, a fatal side effect, can be appropriately treated if we can predict its risk of development before starting chemotherapy. The nicotinamide phosphoribosyltrans...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
